查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827810

2025年心臟病診斷全球市場報告

Heart Attack Diagnostic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心臟病診斷市場呈現強勁成長勢頭，市場規模從2024年的107.8億美元成長至2025年的115.4億美元，複合年成長率為7.0%。過去幾年的成長可歸因於心臟生物標記的開發、心電圖和影像學檢查方法的普及、診斷通訊協定的標準化、認知和教育力度的提升以及肌鈣蛋白檢測技術的改進。

預計未來幾年心臟病診斷市場規模將強勁成長，到2029年將達到164.6億美元，年複合成長率（CAGR）為9.3%。預測期內的成長可歸因於患者賦權和參與、數據分析和精準醫療、預防醫學計劃、醫療基礎設施建設以及個人化診斷方法。預測期內的主要趨勢包括就地檢驗、高敏肌鈣蛋白檢測、非侵入性影像技術、個人化醫療和遠端監控設備。

心臟病發作診斷包括識別、監測、篩檢和預後診斷方法，以檢驗心臟病發作的診斷。這些診斷方法有助於確定患者所經歷的心臟病發作類型，有助於選擇最有效的治療方法。它們在心臟病診斷中發揮重要作用。

心臟病診斷測試的主要類型包括心電圖 (ECG/EKG)、血液檢查、X 光檢查、超音波心動圖、冠狀動脈導管插入術（血管造影術）、運動壓力測試和磁振造影(MRI)。這些測試透過侵入性和非侵入性程序進行。心電圖 (ECG) 是一種快速測試，透過檢測每次心率期間發生的訊號來評估心臟的電活動和節律。它可用於診斷和監測心臟相關疾病。這些心臟病診斷方法應用於各種醫療機構，包括醫院、門診手術中心、診斷中心和其他最終用戶。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供心臟病診斷市場統計數據，例如全球市場規模、區域佔有率、心臟病診斷市場佔有率的競爭對手、詳細的心臟病診斷細分市場、市場趨勢和機遇，以及在心臟病診斷行業取得成功所需的其他數據。本研究報告提供了完整的展望，詳細分析了心臟病診斷行業的現狀和未來趨勢，涵蓋了您需要的所有資訊。

預測的五年成長率為9.3%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自瑞士和韓國等主要地區的高敏肌鈣蛋白檢測試劑和攜帶式心電圖 (ECG) 分析儀徵收關稅直接影響美國，從而導致心肌梗塞檢測延遲和急診室檢測成本上升。由於互惠關稅以及貿易摩擦和監管加強對全球經濟和貿易的負面影響，其影響也將更加廣泛。

心臟病患病率的不斷上升推動了心臟病診斷市場的成長。心血管疾病 (CVD) 包括影響心臟和血管的各種疾病。心臟病和中風的主要原因包括不健康的飲食、缺乏運動、吸煙和酗酒。診斷心臟病對於評估心臟病發作、中風和心臟衰竭的原因和嚴重程度至關重要。例如，根據英國政府機構健康改善和差異辦公室 2024 年 3 月發布的數據，2023 年英格蘭有超過 1,862,500 人 (3%) 被全科醫生診斷為心臟疾病(CHD)。這一數字表明自 2010 年以來被診斷患有 CHD 的人數比例有所下降。因此，心血管疾病盛行率的不斷上升預計將繼續推動心臟病診斷市場的發展。

預計心肌梗塞診斷市場將在醫療支出不斷成長的推動下實現成長。醫療支出以總醫療支出（包括公共和私人支出）占GDP比率衡量，它創造了有利於創新、研發和基礎設施建設的環境。這種增加的投資正在促進心臟病診斷市場的發展和擴張。一個顯著的例子是美國醫療保險和醫療補助服務中心的《2021-2030 年國家衛生支出 (NHE) 報告》，該報告預測心臟病診斷市場的年成長率為 5.1%，到 2030 年將達到約 6.8 兆美元。隨著醫療保險和醫療補助支出預計會增加，醫療成本的上漲將對心臟病診斷市場產生重大影響。

心臟病診斷市場的一個顯著趨勢是新診斷技術的開發，尤其是人工智慧 (AI) 技術的發展。市場主要企業正在投資最尖端科技，以增強心臟診斷能力。人工智慧可以模擬人類智慧，被用於改善診斷放射學、加速心臟病診斷速度並增強中風治療。例如，2022 年 2 月，西達賽奈醫療中心史密特心臟研究所的醫師科學家開發了一種基於人工智慧的方法。該人工智慧程式擅長識別難以診斷的心臟疾病，並透過識別人眼無法察覺的模式來有效預測準確的診斷結果。這一趨勢代表了心臟病診斷的模式轉移，帶來了準確及時診斷的先進能力。

心臟病診斷市場包括營業單位透過壓力測試、心導管插入術、心臟電腦斷層掃描 (CT)、心臟磁振造影(MRI) 和血管造影術等測試產生的收益。市場價值還包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。心臟病診斷市場還包括用於心臟病診斷的穿戴式心電圖設備、心臟心律調節器、支架和輔助人工心臟(VAD) 的銷售。該市場的價值是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、經銷商、分銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心臟病診斷：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球心臟病診斷市場：成長率分析
  • 全球心臟病診斷市場表現：規模與成長，2019-2024
  • 全球心臟病診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球心臟病診斷：總目標市場（TAM）

第6章 市場細分

  • 全球心臟病診斷市場（按測試類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 心電圖（ECG/EKG）
  • 血液檢查
  • X光
  • 心臟超音波圖
  • 冠狀動脈導管插入術（血管造影術）
  • 運動壓力測試
  • 磁振造影（MRI）
  • 全球心臟病診斷市場（按流程、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 侵入性操作
  • 非侵入性手術
  • 全球心臟病診斷市場（按最終用途產業、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 其他最終用戶
  • 全球心臟病診斷市場：心電圖（ECG 或 EKG）細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 靜態心電圖
  • 心電圖監測
  • 心臟事件記錄器
  • 全球心臟病診斷市場：按血液檢測類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 心臟生物標記
  • 脂質組
  • B型利鈉肽（BNP）
  • 全球心臟病診斷市場：按 X 光、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 胸部X光檢查
  • 血管造影術X光
  • 全球心臟病診斷市場：心臟超音波圖（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 胸前心臟超音波（TTE）
  • 經食道心臟超音波圖（TEE）
  • 多普勒超音波心臟檢查
  • 全球心臟病診斷市場：按冠狀動脈導管插入術（血管造影術）細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 冠動脈攝影術
  • 右心導管檢查
  • 左心導管檢查
  • 全球心臟病診斷市場：依運動壓力測試細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 跑步機壓力測試
  • 藥物壓力測試
  • 核子壓力測試
  • 全球心臟病診斷市場：磁振造影（MRI）細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 心臟MRI
  • 負荷磁振造影
  • 灌注磁振造影

第7章 區域和國家分析

  • 全球心臟病診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球心臟病診斷市場：按國家、表現和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 心臟病診斷市場：競爭格局
  • 心臟病診斷市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • General Electric Co. Overview, Products and Services, Strategy and Financial Analysis
    • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Midmark Corp.
  • Siemens AG
  • Toshiba Corp.
  • Welch Allyn Inc.
  • HILL ROM HOLDINGS Inc.
  • Canon Medical Systems Corporation
  • Bio-Rad Laboratories Inc.
  • Fujifilm Holdings
  • ACS Diagnostics Inc.
  • Beckman Coulter Inc.
  • Schiller AG
  • GE Healthcare
  • HeartFlow
  • Medtronic PLC
  • Cardio Diagnostics Holdings Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年心臟病診斷市場：哪些國家將提供新機會
  • 2029年心臟病診斷市場：細分市場帶來新機會
  • 2029年心臟病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22665u

Heart attack diagnostics encompass methods for identifying, monitoring, screening, and prognosticating to validate the diagnosis of a heart attack. These diagnostics aid in determining the type of heart attack a patient has experienced, facilitating the selection of the most effective treatment. They play a crucial role in diagnosing heart disease.

The primary types of heart attack diagnostic tests include electrocardiogram (ECG/EKG), blood tests, X-ray, echocardiogram, coronary catheterization (angiogram), exercise stress test, and magnetic resonance imaging (MRI). These tests can be conducted through both invasive and non-invasive procedures. An electrocardiogram (ECG) is a rapid test that assesses the heart's electrical activity and rhythm by detecting signals produced during each heartbeat. It is valuable for diagnosing and monitoring heart-related conditions. These heart attack diagnostics are employed in various healthcare settings, including hospitals, ambulatory surgical centers, diagnostic centers, and other end-users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The heart attack diagnostics market research report is one of a series of new reports from The Business Research Company that provides heart attack diagnostics market statistics, including heart attack diagnostics industry global market size, regional shares, competitors with a heart attack diagnostics market share, detailed heart attack diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the heart attack diagnostics industry. This heart attack diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The heart attack diagnostic market size has grown strongly in recent years. It will grow from $10.78 billion in 2024 to $11.54 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to development of cardiac biomarkers, introduction of ECG and imaging, standardization of diagnostic protocols, awareness and education initiatives, improvements in troponin testing.

The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $16.46 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to patient empowerment and engagement, data analytics and precision medicine, preventive healthcare initiatives, healthcare infrastructure development, personalized diagnostic approaches. Major trends in the forecast period include point-of-care testing, high-sensitivity troponin tests, non-invasive imaging techniques, personalized medicine, remote monitoring devices.

The forecast of 9.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on high-sensitivity troponin assay reagents and portable electrocardiogram (ECG) analyzers, sourced from key regions such as Switzerland and South Korea, which could lead to delayed myocardial infarction detection and higher emergency department testing costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiac disorders is driving the growth of the heart attack diagnostics market. Cardiovascular diseases (CVD) encompass a range of conditions affecting the heart and blood vessels. Key contributors to heart disease and stroke include unhealthy diets, physical inactivity, tobacco use, and alcohol abuse. Diagnosing heart attacks is crucial for assessing the causes and severity of heart attacks, strokes, and heart failure. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK government entity, revealed that in 2023, over 1,862,500 individuals (3%) in England had received a GP diagnosis of coronary heart disease (CHD). This figure represents a decrease in the percentage of people diagnosed with CHD since the fiscal year ending in 2010. Consequently, the rising incidence of cardiovascular diseases is expected to continue fueling the heart attack diagnostics market.

The heart attack diagnostics market is poised for growth, buoyed by the increasing expenditure in the healthcare sector. Healthcare expenditure, measured as the total cost of healthcare (including public and private spending) as a percentage of GDP, creates an environment conducive to innovation, research, and infrastructure development. This heightened investment contributes to the advancement and expansion of the heart attack diagnostics market. A notable example is the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services, projecting an annual growth rate of 5.1%, reaching nearly $6.8 trillion by 2030. The anticipated growth in Medicare and Medicaid spending further underscores the significant impact of increased healthcare expenditure on the heart attack diagnostics market.

An influential trend in the heart attack diagnostics market is the development of novel diagnostic techniques, particularly leveraging artificial intelligence (AI). Major players in the market are investing in cutting-edge technologies to enhance heart disease diagnosis. AI, an emulation of human intellect, is being deployed to improve diagnostic radiography, expedite heart problem diagnoses, and enhance stroke treatment. For instance, in February 2022, the development of an AI-based method by physician-scientists at Cedars-Sinai's Smidt Heart Institute. This AI program excels in identifying hard-to-diagnose cardiac conditions, effectively predicting accurate diagnoses by recognizing patterns invisible to the human eye. This trend signifies a paradigm shift in heart attack diagnostics, ushering in advanced capabilities for accurate and timely diagnoses.

Major companies in the heart attack diagnostics market are at the forefront of innovation, introducing groundbreaking products such as coronary heart disease detection tests. These tests are designed to identify the presence of coronary heart disease, characterized by the narrowing or blockage of coronary arteries. For instance, in August 2023, A notable product in this category is the PrecisionCHD test launched by Cardio Diagnostics Holdings Inc. This blood-based detection method for Coronary Heart Disease (CHD) uniquely integrates epigenetic and genetic biomarkers with Artificial Intelligence (AI). Notably, the PrecisionCHD test provides a rapid and efficient alternative to traditional CHD detection tools, offering convenience with a straightforward blood sample and swift results within 10 business days. This innovation reflects the commitment of major companies to meet evolving customer needs, drive sales, and elevate revenue in the heart attack diagnostics market.

In August 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired V-Wave Inc. for an undisclosed sum. This acquisition is part of Johnson & Johnson's strategy to enhance its portfolio, foster innovation, and broaden its market presence in the healthcare sector. V-Wave Inc., based in California, specializes in creating advanced medical devices and therapies aimed at managing heart failure.

Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Hitachi Ltd., Koninklijke Philips NV, Midmark Corp., Siemens AG, Toshiba Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., Fujifilm Holdings, ACS Diagnostics Inc., Beckman Coulter Inc., Schiller AG, GE Healthcare, HeartFlow, Medtronic PLC, Cardio Diagnostics Holdings Inc., Becton Dickinson and Company, Danaher Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Quest Diagnostics, Roche Diagnostics, Thermo Fisher Scientific Inc.

North America was the largest region in the heart attack diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the heart attack diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heart attack diagnostics market includes revenues earned by entities through tests such as stress tests, cardiac catheterization, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), and angiogram. The market value includes the value of related goods sold by the service provider or included within the service offering. The heart attack diagnostics market also includes sales of wearable ECG devices, cardiac pacemakers, stents, and ventricular assist devices (VADs) which are used in heart attack diagnostics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heart Attack Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heart attack diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for heart attack diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart attack diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Electrocardiogram (ECG Or EKG); Blood Tests; X-Ray; Echocardiogram; Coronary Catheterization (Angiogram); Exercise Stress Test; Magnetic Resonance Imaging (MRI)
  • 2) By Procedure: Invasive Procedure; Non-Invasive Procedure
  • 3) By End-Use Industry: Hospitals; Ambulatory Surgical Centers; Diagnostics Centers; Other End-Users
  • Subsegments:
  • 1) By Electrocardiogram (ECG Or EKG): Resting ECG; Holter Monitor; Event Monitor
  • 2) By Blood Tests: Cardiac Biomarkers; Lipid Panel; B-Type Natriuretic Peptide (BNP)
  • 3) By X-Ray: Chest X-Ray; Angiography X-Ray
  • 4) By Echocardiogram: Transthoracic Echocardiogram (TTE); Transesophageal Echocardiogram (TEE); Doppler Echocardiogram
  • 5) By Coronary Catheterization (Angiogram): Coronary Angiography; Right Heart Catheterization; Left Heart Catheterization
  • 6) By Exercise Stress Test: Treadmill Stress Test; Pharmacologic Stress Test; Nuclear Stress Test
  • 7) By Magnetic Resonance Imaging (MRI): Cardiac MRI; Stress MRI; Perfusion MRI
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche AG; General Electric Co.; Hitachi Ltd.; Koninklijke Philips NV; Midmark Corp.; Siemens AG; Toshiba Corp.; Welch Allyn Inc.; HILL ROM HOLDINGS Inc.; Canon Medical Systems Corporation; Bio-Rad Laboratories Inc.; Fujifilm Holdings; ACS Diagnostics Inc.; Beckman Coulter Inc.; Schiller AG; GE Healthcare; HeartFlow; Medtronic PLC; Cardio Diagnostics Holdings Inc.; Becton Dickinson and Company; Danaher Corporation; Edwards Lifesciences Corporation; Johnson & Johnson; Quest Diagnostics; Roche Diagnostics; Thermo Fisher Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Heart Attack Diagnostic Market Characteristics

3. Heart Attack Diagnostic Market Trends And Strategies

4. Heart Attack Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Heart Attack Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Heart Attack Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Heart Attack Diagnostic Market Growth Rate Analysis
  • 5.4. Global Heart Attack Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Heart Attack Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Heart Attack Diagnostic Total Addressable Market (TAM)

6. Heart Attack Diagnostic Market Segmentation

  • 6.1. Global Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrocardiogram (ECG/EKG)
  • Blood Tests
  • X-Ray
  • Echocardiogram
  • Coronary Catheterization (Angiogram)
  • Exercise Stress Test
  • Magnetic Resonance Imaging (MRI)
  • 6.2. Global Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Invasive Procedure
  • Non-Invasive Procedure
  • 6.3. Global Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Centers
  • Other End-Users
  • 6.4. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Electrocardiogram (ECG Or EKG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Resting ECG
  • Holter Monitor
  • Event Monitor
  • 6.5. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Blood Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Biomarkers
  • Lipid Panel
  • B-Type Natriuretic Peptide (BNP)
  • 6.6. Global Heart Attack Diagnostic Market, Sub-Segmentation Of X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chest X-Ray
  • Angiography X-Ray
  • 6.7. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Echocardiogram, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transthoracic Echocardiogram (TTE)
  • Transesophageal Echocardiogram (TEE)
  • Doppler Echocardiogram
  • 6.8. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Coronary Catheterization (Angiogram), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Angiography
  • Right Heart Catheterization
  • Left Heart Catheterization
  • 6.9. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Exercise Stress Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Treadmill Stress Test
  • Pharmacologic Stress Test
  • Nuclear Stress Test
  • 6.10. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac MRI
  • Stress MRI
  • Perfusion MRI

7. Heart Attack Diagnostic Market Regional And Country Analysis

  • 7.1. Global Heart Attack Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Heart Attack Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Heart Attack Diagnostic Market

  • 8.1. Asia-Pacific Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Heart Attack Diagnostic Market

  • 9.1. China Heart Attack Diagnostic Market Overview
  • 9.2. China Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Heart Attack Diagnostic Market

  • 10.1. India Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Heart Attack Diagnostic Market

  • 11.1. Japan Heart Attack Diagnostic Market Overview
  • 11.2. Japan Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Heart Attack Diagnostic Market

  • 12.1. Australia Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Heart Attack Diagnostic Market

  • 13.1. Indonesia Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Heart Attack Diagnostic Market

  • 14.1. South Korea Heart Attack Diagnostic Market Overview
  • 14.2. South Korea Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Heart Attack Diagnostic Market

  • 15.1. Western Europe Heart Attack Diagnostic Market Overview
  • 15.2. Western Europe Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Heart Attack Diagnostic Market

  • 16.1. UK Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Heart Attack Diagnostic Market

  • 17.1. Germany Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Heart Attack Diagnostic Market

  • 18.1. France Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Heart Attack Diagnostic Market

  • 19.1. Italy Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Heart Attack Diagnostic Market

  • 20.1. Spain Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Heart Attack Diagnostic Market

  • 21.1. Eastern Europe Heart Attack Diagnostic Market Overview
  • 21.2. Eastern Europe Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Heart Attack Diagnostic Market

  • 22.1. Russia Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Heart Attack Diagnostic Market

  • 23.1. North America Heart Attack Diagnostic Market Overview
  • 23.2. North America Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Heart Attack Diagnostic Market

  • 24.1. USA Heart Attack Diagnostic Market Overview
  • 24.2. USA Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Heart Attack Diagnostic Market

  • 25.1. Canada Heart Attack Diagnostic Market Overview
  • 25.2. Canada Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Heart Attack Diagnostic Market

  • 26.1. South America Heart Attack Diagnostic Market Overview
  • 26.2. South America Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Heart Attack Diagnostic Market

  • 27.1. Brazil Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Heart Attack Diagnostic Market

  • 28.1. Middle East Heart Attack Diagnostic Market Overview
  • 28.2. Middle East Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Heart Attack Diagnostic Market

  • 29.1. Africa Heart Attack Diagnostic Market Overview
  • 29.2. Africa Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Heart Attack Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Heart Attack Diagnostic Market Competitive Landscape
  • 30.2. Heart Attack Diagnostic Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. General Electric Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

31. Heart Attack Diagnostic Market Other Major And Innovative Companies

  • 31.1. Midmark Corp.
  • 31.2. Siemens AG
  • 31.3. Toshiba Corp.
  • 31.4. Welch Allyn Inc.
  • 31.5. HILL ROM HOLDINGS Inc.
  • 31.6. Canon Medical Systems Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Fujifilm Holdings
  • 31.9. ACS Diagnostics Inc.
  • 31.10. Beckman Coulter Inc.
  • 31.11. Schiller AG
  • 31.12. GE Healthcare
  • 31.13. HeartFlow
  • 31.14. Medtronic PLC
  • 31.15. Cardio Diagnostics Holdings Inc.

32. Global Heart Attack Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Heart Attack Diagnostic Market

34. Recent Developments In The Heart Attack Diagnostic Market

35. Heart Attack Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Heart Attack Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Heart Attack Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Heart Attack Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer